China: A new study, published in Diabetes, Metabolic Syndrome and Obesity, has shed light on the potential role of specific ...

A new study published in the journal of Diabetes Research and Clinical Practice showed that higher stroke risk is associated ...

Apart from simple diagnosis, the study takes an important step toward predictive health monitoring by modeling the risk of ...

Aging men aren't just battling time—they're up against rising blood sugar. New research reveals that subtle increases in ...

Yes, diabetes can cause a plethora of eye issues; some of them can make you go blind. The diabetic eye diseases include ...

Kirsty, Biocon's rapid-acting insulin, is the first FDA-approved interchangeable biosimilar to NovoLog in the US and will be ...

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog, expanding their insulin ...

Fecal microbiota analysis of pregnant women may provide early identification of those at risk for gestational diabetes.

Discover a study highlighting the high prevalence of MASLD and liver fibrosis in patients with type 2 diabetes using ...

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog. This rapid-acting insulin ...

Biocon Biologics Ltd today announced that the U.S. Food and Drug Administration has approved Kirsty™ (Insulin Aspart-xjhz), ...

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE ...